Research Nester has recently announced its latest research on “Precision Cancer Imaging Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global precision cancer imaging market in terms of market segmentation by imaging technique, by end user and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

Precision cancer imaging offers early detection and diagnosis of cancer by providing images of the affected area after thorough screening of the body. Medical imaging of cancer is used to monitor the disease as well as check recurring growth after the treatment. The diagnostic method takes into consideration various factors including genetic and environmental conditions of an individual, providing highly accurate and precise information to the patients and the doctors.

The market for precision cancer imaging is anticipated to record a substantial CAGR during the forecast period, i.e., 2019-2027. The growth of the market can be attributed to growing cases of cancer among the population, mainly including the older population. The World Health Organization reported that 1 out of every 6 deaths occur owing to cancer, which was estimated to be around 9.6 million deaths in 2018.

The market is segmented by imaging technique, by end user and by region. On the basis of end user, the market is further segmented into hospitals, clinics, diagnostic & imaging centers and others, out of which, the hospitals segment is anticipated to grow at the highest rate during the forecast period on account of increasing prevalence of various types of cancer and growing geriatric population around the world. The growing number of cancer patients in hospitals is estimated to increase the demand for precision cancer imaging techniques.

Geographically, precision cancer imaging market in North America region is anticipated to hold the largest market share during the forecast period as a result of growing developments and increasing availability of advanced imaging techniques in the region which provide improved results. The market in Asia-Pacific region is estimated to grow at the highest rate during the forecast period on account of progressing healthcare industry as well as growing population in the region.

Rising Geriatric Population To Boost The Market Growth

According to the American Cancer Society, people older than the age of 85 are highly susceptible to cancer. In 2019, people aged 85 and above are estimated to account for 17% of the total number of cancer deaths in the U.S. The growing elderly population is a major factor that is estimated to boost the market growth during the forecast period.

However, the high cost of precision cancer imaging tests is anticipated to restrict the market growth as population belonging to the lower and middle income countries, cannot afford such diagnostic tests.

This report also provides the existing competitive scenario of some of the key players of the global precision cancer imaging market which includes company profiling of Becton, Dickinson and Company, Thermo Fisher Scientific, Siemens Medical Solutions, F. Hoffmann-La Roche, Canon Medical Systems, bioMérieux, General Electric Company, Koninklijke Philips N.V., Hitachi Medical Systems and Canon Medical Systems. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global precision cancer imaging market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.